Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Martin Lord

6PUBLICATIONS
44CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationshipsVeterinary virologyCellular immunologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

Sort by Publication Date:
|Nov 05, 2024
A bispecific CD40 agonistic antibody allowing for antibody-peptide conjugate formation to enable cancer-specific peptide delivery, resulting in improved T proliferation and anti-tumor immunity in mice.

Aman Mebrahtu, Ida Laurén, Rosanne Veerman

|Jan 18, 2024
SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma.

Mohammad Hamdy Abdelrazak Morsy, Ingrid Lilienthal, Martin Lord

|Apr 06, 2023
Epitopes Displayed in a Cyclic Peptide Scaffold Bind SARS-COV-2 Antibodies.

Camilla Eriksson, Sunithi Gunasekera, Taj Muhammad

|Sep 30, 2021
An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses.

Sara M Mangsbo, Sebastian Havervall, Ida Laurén

|Aug 30, 2021
Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.

Sebastian Havervall, Henry Ng, August Jernbom Falk

|Jul 02, 2021
Plasma Proteomic Analysis in Non-Small Cell Lung Cancer Patients Treated with PD-1/PD-L1 Blockade.

Mohamed Eltahir, Johan Isaksson, Johanna Sofia Margareta Mattsson

Pageof 1

Frequent Collaborators

5 joint publications

Sara Mangsbo

2 joint publications

August Jernbom Falk

2 joint publications

Ida Laurén

2 joint publications

Sophia Hober

2 joint publications

Pierre Dönnes

1 joint publications

Mohamed Eltahir

1 joint publications

Patrick Micke

1 joint publications

Juan Astorga-Wells

1 joint publications

Henry Ng

1 joint publications

Anna Månberg

Frequent Collaborators

5 joint publications

Sara Mangsbo

2 joint publications

August Jernbom Falk

2 joint publications

Ida Laurén

2 joint publications

Sophia Hober

Top Related Videos

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on : Mar 08, 2018

7.6K
A High-Throughput Enzyme-Coupled Activity Assay to Probe Small Molecule Interaction with the dNTPase SAMHD1
08:17

A High-Throughput Enzyme-Coupled Activity Assay to Probe Small Molecule Interaction with the dNTPase SAMHD1

Published on : Apr 16, 2021

2.4K
Engineering Antiviral Agents <em>via</em> Surface Plasmon Resonance
13:00

Engineering Antiviral Agents <em>via</em> Surface Plasmon Resonance

Published on : Jun 14, 2022

2.4K
See more related videos

Top Related Videos

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on : Mar 08, 2018

7.6K
A High-Throughput Enzyme-Coupled Activity Assay to Probe Small Molecule Interaction with the dNTPase SAMHD1
08:17

A High-Throughput Enzyme-Coupled Activity Assay to Probe Small Molecule Interaction with the dNTPase SAMHD1

Published on : Apr 16, 2021

2.4K
Engineering Antiviral Agents <em>via</em> Surface Plasmon Resonance
13:00

Engineering Antiviral Agents <em>via</em> Surface Plasmon Resonance

Published on : Jun 14, 2022

2.4K
See more related videos